Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Huttig Building Products, Inc. stock logo
HBP
Huttig Building Products
$10.70
$10.70
$3.95
$11.35
$292.42M2.38327,575 shs54 shs
Optical Cable Co. stock logo
OCC
Optical Cable
$2.85
-5.0%
$2.89
$2.26
$4.65
$22.37M0.516,134 shs186 shs
OncoCyte Co. stock logo
OCX
OncoCyte
$2.48
+1.6%
$2.90
$2.08
$6.20
$20.51M0.847,466 shs13,331 shs
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Huttig Building Products, Inc. stock logo
HBP
Huttig Building Products
0.00%0.00%0.00%0.00%0.00%
Optical Cable Co. stock logo
OCC
Optical Cable
+7.14%+8.66%+3.81%+9.09%-27.18%
OncoCyte Co. stock logo
OCX
OncoCyte
-0.81%-4.69%-19.74%-22.04%-50.71%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Huttig Building Products, Inc. stock logo
HBP
Huttig Building Products
N/AN/AN/AN/AN/AN/AN/AN/A
Optical Cable Co. stock logo
OCC
Optical Cable
N/AN/AN/AN/AN/AN/AN/AN/A
OncoCyte Co. stock logo
OCX
OncoCyte
1.8024 of 5 stars
3.32.00.00.02.92.50.0

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Huttig Building Products, Inc. stock logo
HBP
Huttig Building Products
N/AN/AN/AN/A
Optical Cable Co. stock logo
OCC
Optical Cable
N/AN/AN/AN/A
OncoCyte Co. stock logo
OCX
OncoCyte
2.50
Moderate Buy$4.0663.81% Upside

Current Analyst Ratings

Latest OCX, OBD, IMM, OCC, and HBP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/24/2024
OncoCyte Co. stock logo
OCX
OncoCyte
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$3.60 ➝ $4.25
4/17/2024
OncoCyte Co. stock logo
OCX
OncoCyte
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingEqual Weight ➝ Equal Weight$4.00
4/15/2024
OncoCyte Co. stock logo
OCX
OncoCyte
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSpeculative Buy ➝ Speculative Buy$5.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Huttig Building Products, Inc. stock logo
HBP
Huttig Building Products
$937.80M0.31$1.97 per share5.43$3.40 per share3.15
Optical Cable Co. stock logo
OCC
Optical Cable
$72.17M0.31$0.63 per share4.52$3.13 per share0.91
OncoCyte Co. stock logo
OCX
OncoCyte
$1.50M13.67N/AN/A$2.48 per share1.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Huttig Building Products, Inc. stock logo
HBP
Huttig Building Products
$48.50M$1.776.05N/A5.17%66.00%15.67%N/A
Optical Cable Co. stock logo
OCC
Optical Cable
$2.07M-$0.03N/AN/A-0.24%-6.09%-3.45%6/10/2024 (Estimated)
OncoCyte Co. stock logo
OCX
OncoCyte
-$27.78MN/A0.00N/A-1,890.62%-96.30%-41.12%5/9/2024 (Estimated)

Latest OCX, OBD, IMM, OCC, and HBP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/13/2024Q1 2024
Optical Cable Co. stock logo
OCC
Optical Cable
N/A-$0.18-$0.18-$0.18N/A$14.86 million  

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Huttig Building Products, Inc. stock logo
HBP
Huttig Building Products
N/AN/AN/AN/AN/A
Optical Cable Co. stock logo
OCC
Optical Cable
N/AN/AN/AN/AN/A
OncoCyte Co. stock logo
OCX
OncoCyte
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Huttig Building Products, Inc. stock logo
HBP
Huttig Building Products
0.75
2.05
0.95
Optical Cable Co. stock logo
OCC
Optical Cable
0.43
4.73
1.31
OncoCyte Co. stock logo
OCX
OncoCyte
N/A
1.49
1.49

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Huttig Building Products, Inc. stock logo
HBP
Huttig Building Products
54.10%
Optical Cable Co. stock logo
OCC
Optical Cable
13.61%
OncoCyte Co. stock logo
OCX
OncoCyte
55.35%

Insider Ownership

CompanyInsider Ownership
Huttig Building Products, Inc. stock logo
HBP
Huttig Building Products
10.95%
Optical Cable Co. stock logo
OCC
Optical Cable
23.00%
OncoCyte Co. stock logo
OCX
OncoCyte
1.94%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Huttig Building Products, Inc. stock logo
HBP
Huttig Building Products
1,10027.33 million24.34 millionOptionable
Optical Cable Co. stock logo
OCC
Optical Cable
3277.85 million6.05 millionNot Optionable
OncoCyte Co. stock logo
OCX
OncoCyte
758.27 million8.11 millionNo Data

OCX, OBD, IMM, OCC, and HBP Headlines

SourceHeadline
OncoCyte (NASDAQ:OCX) Given New $4.25 Price Target at Needham & Company LLCOncoCyte (NASDAQ:OCX) Given New $4.25 Price Target at Needham & Company LLC
americanbankingnews.com - April 25 at 5:26 AM
Strong Future Outlook for OncoCyte: Buy Rating and Increased Price Target Amid Positive Partnerships and Financial EfficiencyStrong Future Outlook for OncoCyte: Buy Rating and Increased Price Target Amid Positive Partnerships and Financial Efficiency
markets.businessinsider.com - April 24 at 6:06 PM
OncoCyte (NASDAQ:OCX) Earns Sell Rating from Analysts at StockNews.comOncoCyte (NASDAQ:OCX) Earns Sell Rating from Analysts at StockNews.com
americanbankingnews.com - April 24 at 2:22 AM
Buffett Grabs More of This Stock, Plus Other Notable Insider BuyingBuffett Grabs More of This Stock, Plus Other Notable Insider Buying
msn.com - April 22 at 12:51 AM
Stephens Reiterates "Equal Weight" Rating for OncoCyte (NASDAQ:OCX)Stephens Reiterates "Equal Weight" Rating for OncoCyte (NASDAQ:OCX)
americanbankingnews.com - April 19 at 5:50 AM
OncoCyte (NASDAQ:OCX) Now Covered by StockNews.comOncoCyte (NASDAQ:OCX) Now Covered by StockNews.com
americanbankingnews.com - April 18 at 2:30 AM
OncoCyte Co. (NASDAQ:OCX) CEO Josh Riggs Buys 3,390 SharesOncoCyte Co. (NASDAQ:OCX) CEO Josh Riggs Buys 3,390 Shares
americanbankingnews.com - April 16 at 6:58 AM
OncoCyte Co. (NASDAQ:OCX) Director Andrew Arno Acquires 33,898 Shares of StockOncoCyte Co. (NASDAQ:OCX) Director Andrew Arno Acquires 33,898 Shares of Stock
americanbankingnews.com - April 16 at 5:44 AM
OncoCyte (NASDAQ:OCX) Given Speculative Buy Rating at BenchmarkOncoCyte (NASDAQ:OCX) Given Speculative Buy Rating at Benchmark
americanbankingnews.com - April 16 at 4:50 AM
OncoCyte Co. (NASDAQ:OCX) CEO Buys $10,000.50 in StockOncoCyte Co. (NASDAQ:OCX) CEO Buys $10,000.50 in Stock
insidertrades.com - April 16 at 4:46 AM
OncoCyte Co. (NASDAQ:OCX) Major Shareholder Broadwood Partners, L.P. Buys 2,420,000 Shares of StockOncoCyte Co. (NASDAQ:OCX) Major Shareholder Broadwood Partners, L.P. Buys 2,420,000 Shares of Stock
americanbankingnews.com - April 16 at 4:18 AM
OncoCyte Corporation (OCX) Q4 2023 Earnings Call TranscriptOncoCyte Corporation (OCX) Q4 2023 Earnings Call Transcript
seekingalpha.com - April 13 at 10:47 PM
Q4 2023 OncoCyte Corp Earnings CallQ4 2023 OncoCyte Corp Earnings Call
finance.yahoo.com - April 13 at 1:38 AM
OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q4 2023OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q4 2023
investorplace.com - April 12 at 12:00 PM
Top 3 Health Care Stocks That May Collapse In Q2Top 3 Health Care Stocks That May Collapse In Q2
msn.com - April 12 at 10:36 AM
OncoCyte Corporation: Oncocyte and Bio-Rad Partner on Global Launch of Transplant AssayOncoCyte Corporation: Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
finanznachrichten.de - April 12 at 10:10 AM
S&P Futures Tick Lower as Investors Digest Big Bank EarningsS&P Futures Tick Lower as Investors Digest Big Bank Earnings
msn.com - April 12 at 10:10 AM
S&P Futures Tick Lower as Investors Cautiously Await U.S. Big Bank EarningsS&P Futures Tick Lower as Investors Cautiously Await U.S. Big Bank Earnings
msn.com - April 12 at 7:32 AM
Oncocyte announces $15.8 mln private placement of securitiesOncocyte announces $15.8 mln private placement of securities
msn.com - April 12 at 7:32 AM
ONCOCYTE REPORTS Full Year 2023 FINANCIAL RESULTSONCOCYTE REPORTS Full Year 2023 FINANCIAL RESULTS
prismmediawire.com - April 12 at 6:00 AM
Oncocyte Reports Full Year 2023 Financial ResultsOncocyte Reports Full Year 2023 Financial Results
globenewswire.com - April 12 at 6:00 AM
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq RulesOncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
prismmediawire.com - April 11 at 9:48 PM
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq RulesOncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
globenewswire.com - April 11 at 9:46 PM
Oncocyte and Bio-Rad Partner on Global Launch of Transplant AssayOncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
globenewswire.com - April 11 at 5:30 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Huttig Building Products logo

Huttig Building Products

NASDAQ:HBP
Huttig Building Products, Inc., together with its subsidiaries, distributes millwork, building materials, and wood products for new residential construction, in-home improvement, remodeling, and repair works in the United States. The company offers various millwork products, including exterior and interior doors, pre-hung and factory finished door units, windows, patio doors, mouldings, frames, stair parts, and columns under the Therma-Tru, Masonite, Woodgrain, HB&G, Simpson Door, Final Frame, BrasPine, Arauco, Windsor Windows, and Rogue Valley Door brands. It also provides general building products, such as fasteners and connectors, roofing, siding, insulation, flashing, housewrap, decking, railings, and other miscellaneous building products under the Huttig-Grip, Louisiana-Pacific, Simpson Strong-Tie, TimberTech, AZEK, RDI, GAF Roofing, Maibec, Knauf, GCP Technologies, Fiberon, Alpha Protech, MFM, Lomanco, and Fortifiber brands. In addition, the company offers wood products comprising engineered wood products used in floor systems, wood panels, and lumber; and value-added services, such as floor system take-offs, cut-to-length packages and just-in-time, and cross-dock delivery under the Louisiana-Pacific and Rosboro brands. It markets and sells its products through a network of 25 wholesale distribution centers serving approximately 41 states to building materials dealers, national buying groups, home centers, and industrial users comprising makers of manufactured homes. Huttig Building Products, Inc. was founded in 1865 and is headquartered in St. Louis, Missouri.
Optical Cable logo

Optical Cable

NASDAQ:OCC
Optical Cable Corporation, together with its subsidiaries, engages in the manufacture and sale of fiber optic and copper data communications cabling and connectivity solutions primarily for the enterprise market in the United States and internationally. The company provides fiber optic and hybrid cables for high bandwidth transmission of data, video, and voice communications; and copper datacom cables, including unshielded and shielded twisted pair constructions. Its fiber optic connectivity products include fiber optic wall mounts, cabinet mount and rack mount enclosures, pre-terminated fiber optic enclosures, fiber optic connectors, splice trays, fiber optic jumpers, plug and play cassette modules, pre-terminated fiber optic cable assemblies, adapters, and accessories; and copper connectivity products comprising category compliant patch panels, jacks, plugs, patch cords, faceplates, surface mounted boxes, distribution and multi-media boxes, copper rack mount and wall mount enclosures, cable assemblies, cable organizers, and other wiring products for equipment rooms, telecommunications closets, data centers, and workstation applications. In addition, the company offers network, data storage, and telecommunications management systems, such as data cabinets, wall mount enclosures, horizontal and vertical cable management systems, and open frame relay racks; and datacom wiring products, including various enclosures, and modules and modular outlets for single dwelling and multiple dwelling residential uses. Further, it provides specialty fiber optic connectors and connectivity components, copper datacom connectors, and related systems and solutions for military, other harsh environment, and special applications, as well as cylindrical connector products. The company sells its products to distributors, original equipment manufacturers, value-added resellers, and end-users. Optical Cable Corporation was incorporated in 1983 and is headquartered in Roanoke, Virginia.
OncoCyte logo

OncoCyte

NASDAQ:OCX
OncoCyte Corporation, a molecular diagnostics company, research, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, biopharma, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.